Results 111 to 120 of about 518 (147)

Dynamic Changes in Viral Loads during Co-Infection with a Recombinant Turkey Herpesvirus Vector Vaccine and Very Virulent Marek's Disease Virus In Vivo. [PDF]

Viruses
Ding T, Xiong M, Xu Y, Pu X, Wang QS, Xu MR, Shao HX, Qian K, Dang HB, Qin AJ.   +9 more
europepmc   +1 more source

Advances in the application of recombinant herpesvirus-vectored vaccines in animal disease control. [PDF]

Front Microbiol
Guo J, Mei C, Sun X, Lin Q, Bu W, Xie S, Jiang B.   +6 more
europepmc   +1 more source

Marek's disease: A global challenge to poultry health and productivity. [PDF]

Open Vet J
Mulyati S, Mustofa I, Khairullah AR, Kusala MKJ, Fauziah I, Ahmad RZ, Ekawasti F, Prihandani SS, Furqoni AH, Wardhani BWK, Kurniasih DAA, Khalisa AT, Moses IB, Akintunde AO, Pratama BP, Raharjo PP, Fauzia KA, Wibowo S.   +17 more
europepmc   +1 more source

Molecular characterization of the meq oncogene of Marek's disease virus in vaccinated Brazilian poultry farms reveals selective pressure on prevalent strains. [PDF]

Vet Q
Chacón RD, Sánchez-Llatas CJ, L Pajuelo S, Diaz Forero AJ, Jimenez-Vasquez V, Médico JA, Soto-Ugaldi LF, Astolfi-Ferreira CS, Piantino Ferreira AJ.   +8 more
europepmc   +1 more source

The Development of a Sensitive Droplet Digital Polymerase Chain Reaction Test for Quantitative Detection of Goose Astrovirus. [PDF]

Viruses
Shi J, Jin Q, Zhang X, Zhao J, Li N, Dong B, Yu J, Yao L.   +7 more
europepmc   +1 more source

Virological perspectives of the current situation of oncogenic viruses in Egypt: a review. [PDF]

Infect Agent Cancer
Ibrahim AH, El-Habbaa AS, El-Nahas EM.
europepmc   +1 more source

Variations in the H/ACA box sequence of viral telomerase RNA of isolates of CVI988 Rispens vaccine

Archives of Virology, 2008
The use of the complete DNA sequence for the Marek's disease virus (MDV) serotype 1 vaccine strain CVI988 Rispens in comparative genomic studies with virulent strains of MDV has revealed the presence of a number of insertions, deletions and single-nucleotide polymorphisms.
Denis Rasschaert
exaly   +6 more sources

Effects of Rispens CVI988 vaccination followed by challenge with Marek’s disease viruses of differing virulence on the replication kinetics and shedding of the vaccine and challenge viruses

Veterinary Microbiology, 2016
Vaccination with "imperfect" vaccines that prevent disease but not infection is strongly implicated in the observed increased virulence of Marek's disease virus (MDV) over the past six decades. The current "gold standard" vaccine, Rispens CVI988 (Rispens), has maintained efficacy despite use for five decades, raising the question of whether it too ...
Sithara Ralapanawe, Stephen W Walkden-Brown   +1 more
exaly   +4 more sources

Differentiation between pathogenic serotype 1 isolates of Marek's disease virus and the Rispens CVI988 vaccine in Australia using real-time PCR and high resolution melt curve analysis

Journal of Virological Methods, 2013
Two real-time PCR assays were developed which enable quantitation and differentiation between pathogenic Australian isolates of Marek's disease virus (MDV) serotype 1 and the serotype 1 vaccine strain Rispens CVI988. The assays are based on a DNA sequence variation in the meq gene between pathogenic and vaccinal MDV1 which has been confirmed by ...
Stephen W Walkden-Brown, S W Walkden-Brown   +1 more
exaly   +4 more sources

Some of the next articles are maybe not open access.

Related searches:

In vitro characterization of the Meq proteins of Marek's disease virus vaccine strain CVI988

Virus Research, 2009
Gallid herpesvirus 2 (GaHV-2), commonly known as Marek's disease virus serotype-1 (MDV-1), causes T cell lymphomas in chickens. Vaccines prepared from the attenuated CVI988/Rispens MDV-1 strain currently offer the best protection. Although attenuated CVI988/Rispens is non-oncogenic, it codes for at least two forms of the MDV oncoprotein Meq, and these ...
Reddy, Sanjay, Blanca Lupiani, Hsing-Jien Kung   +2 more
exaly   +3 more sources